Kyverna Therapeutics (KYTX) Assets (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Assets of $257.0 million for Q1 2026, down 12.53% on a QoQ basis from $293.8 million in Q4 2025, and down 1.39% year-over-year from $260.7 million in Q1 2025.
Kyverna Therapeutics (KYTX) Assets (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Assets history runs 4 years deep, the most recent figure standing at $257.0 million for Q1 2026.
- Quarterly Assets fell 1.39% year-over-year to $257.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $257.0 million (down 1.39% YoY) and the FY2025 annual result came in at $293.8 million, down 3.55% from the prior year.
- Assets was $257.0 million for Q1 2026 at Kyverna Therapeutics, down from $293.8 million in the prior quarter.
- Across five years, Assets topped out at $390.0 million in Q1 2024 and bottomed at $75.2 million in Q4 2023.
- A 4-year average of $269.7 million and a median of $277.2 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets surged 305.14% — and 2025, when it slumped 44.82%.
- Kyverna Therapeutics' Assets stood at $75.2 million in 2023, then jumped by 305.14% to $304.6 million in 2024, then fell by 3.55% to $293.8 million in 2025, then slipped by 12.53% to $257.0 million in 2026.
- Business Quant data shows KYTX's Assets at $257.0 million in Q1 2026, $293.8 million in Q4 2025, and $187.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | 257.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257.02 Mn |
| Dec 31, 2025 | 293.83 Mn |
| Sep 30, 2025 | 187.16 Mn |
| Jun 30, 2025 | 226.51 Mn |
| Mar 31, 2025 | 260.66 Mn |
| Dec 31, 2024 | 304.65 Mn |
| Sep 30, 2024 | 339.20 Mn |
| Jun 30, 2024 | 363.12 Mn |
| Mar 31, 2024 | 389.98 Mn |
| Dec 31, 2023 | 75.20 Mn |